Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 963208, 8 pages
http://dx.doi.org/10.1155/2014/963208
Review Article

Sanqi Panax Notoginseng Injection for Angina Pectoris

Department of Cardiology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beixiange 5, Xicheng District, Beijing 100053, China

Received 8 December 2013; Revised 27 December 2013; Accepted 31 December 2013; Published 16 February 2014

Academic Editor: Bo Feng

Copyright © 2014 Xiaochen Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Rapaport, R. Bernard, and E. Corday, “Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature,” Circulation, vol. 59, no. 3, pp. 607–609, 1979. View at Google Scholar · View at Scopus
  2. A. Jain, V. Wadehra, and A. D. Timmis, “Management of stable angina,” Postgraduate Medical Journal, vol. 79, no. 932, pp. 332–336, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Chipperfield and J. R. Chipperfield, “Differences in metal content of the heart muscle in death from ischemic heart disease,” The American Heart Journal, vol. 95, no. 6, pp. 732–737, 1978. View at Google Scholar · View at Scopus
  4. K. Thygesen, J. S. Alpert, and H. D. White, “Universal definition of myocardial infarction,” Circulation, vol. 116, no. 22, pp. 2634–2653, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Feng, “The epidemiology study of risk factors of angina and myocardial infarction in elderly,” Medical College of Chinese People's Liberation Army, Beijing, China, 2006.
  6. U. Thadani, “Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure,” Cardiovascular Drugs and Therapy, vol. 10, no. 6, pp. 735–742, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Cheng, “Pharmacodynamical research and clinical application of Panax pseudo-ginseng saponins,” Guangxi Medical Journal, vol. 20, no. 6, pp. 1109–1112, 1998. View at Google Scholar
  8. L. M. Yu, Y. K. Deng, F. Yuan et al., “The research progress of Panax Notoginseng Saponins against Myocardial Ischemia,” China Pharmacist, vol. 14, no. 11, pp. 1685–1687, 2011. View at Google Scholar
  9. W. J. Zhang, J. Wojta, and B. R. Binder, “Effect of notoginsenoside R1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary artery,” Cellular and Molecular Biology, vol. 43, no. 4, pp. 581–587, 1997. View at Google Scholar · View at Scopus
  10. S. C. Chen, J. J. Cheng, M. H. Hsieh et al., “Molecular mechanism of the inhibitory effect of trilinolein on endothelin-1-induced hypertrophy of cultured neonatal rat cardiomyocytes,” Planta Medica, vol. 71, no. 6, pp. 525–529, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Lei, W. Tian, L. Q. Zhu, J. Yang, and K. J. Chen, “Effects of Radix Ginseng and Radix Notoginseng formula on secretion of vascular endothelial growth factor and expression of vascular endothelial growth factor receptor-2 in human umbilical vein endothelial cells,” Journal of Chinese Integrative Medicine, vol. 8, no. 4, pp. 368–372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Y. Han, H. X. Li, X. Ma et al., “Evaluation of the anti-myocardial ischemia effect of individual and combined extracts of Panax notoginseng and Carthamus tinctorius in rats,” Journal of Ethnopharmacology, vol. 145, no. 3, pp. 722–727, 2013. View at Google Scholar
  13. W. Xia, C. Sun, Y. Zhao, and L. Wu, “Hypolipidemic and antioxidant activities of sanchi (radix notoginseng) in rats fed with a high fat diet,” Phytomedicine, vol. 18, no. 6, pp. 516–520, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Rhule, B. Rase, J. R. Smith, and D. M. Shepherd, “Toll-like receptor ligand-induced activation of murine DC2.4 cells is attenuated by Panax notoginseng,” Journal of Ethnopharmacology, vol. 116, no. 1, pp. 179–186, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Wang, L. Wu, W. Zhang, and C. Deng, “Effect of Panax notoginseng saponins on vascular intima hyperplasia and PCNA expression in rat aorta after balloon angioplasty,” China Journal of Chinese Materia Medica, vol. 34, no. 6, pp. 735–739, 2009. View at Google Scholar · View at Scopus
  16. Z. Yuan, Y. Liao, G. Tian et al., “Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation,” Journal of Ethnopharmacology, vol. 138, no. 1, pp. 150–155, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Y. Li, X. G. Wang, and M. M. Ma, “Ginsenoside-Rd potentiates apoptosis induced by hydrogen peroxide in basilar artery smooth muscle cells through the mitochondrial pathway,” Apoptosis, vol. 17, no. 2, pp. 113–120, 2012. View at Google Scholar
  18. “Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on standardization of clinical nomenclature,” Circulation, vol. 59, no. 3, pp. 607–609, 1979. View at Scopus
  19. R. J. Gibbons, J. Abrams, P. C. Deedwania et al., “ACC/AHA practice guidelines-ACC/AHA 2002 guideline update for the management of patients with chronic stable angina task force on practice guidelines (committee to update the 1999 guidelines),” Circulation, vol. 107, no. 1, pp. 149–158, 2003. View at Google Scholar
  20. J. P. T. Higgins and S. Green, Corchrane Reviewers’ Handbook 5.1.0, Review Manager (RevMan), 2011.
  21. R. X. Liu, X. H. Liu, G. Q. Duan et al., “Clinical observation and analysis of Sanqi Panax Notoginseng Injection in 73 patients with unstable angina,” Shaanxi Medical Journal, vol. 32, no. 4, pp. 338–343, 2003. View at Google Scholar
  22. T. J. Guo, “Clinical observation and analysis of Sanqi Panax Notoginseng Injection for 50 cases of stable angina,” Chinese Journal of Aerospace Medicine, vol. 21, no. 2, pp. 223–229, 2010. View at Google Scholar
  23. H. Q. Chen, W. Q. Guo, L. J. Ou et al., “Clinical observation of Sanqi Panax Notoginseng Injection in combination of Isosorbide mononitrate for stable angina,” Fujian Journal of Traditional Chinese Medicine, no. 5, pp. 9–10, 2004. View at Google Scholar
  24. H. Ji and X. F. Fan, “Clinical observation of Sanqi Panax Notoginseng Injection for angina pectoris,” Shaanxi Journal of Traditional Chinese Medicine, vol. 26, no. 1, pp. 34–38, 2003. View at Google Scholar
  25. Z. W. Ruan, “Clinical observation of Sanqi Panax Notoginseng Injection in combination of Isosorbide mononitrate for stable angina,” Journal of Emergency in Traditional Chinese Medicine, vol. 19, no. 11, pp. 1867–1870, 2010. View at Google Scholar
  26. Z. Y. Li, “Clinical observation of Sanqi Panax Notoginseng Injection for unstable angina and its effect on the level of CRP,” Journal of Guangxi Medical University, vol. 26, no. 4, pp. 577–587, 2009. View at Google Scholar
  27. H. F. Li, “Clinical observation of Sanqi Panax Notoginseng Injection for unstable angina,” Chinese Journal of Information on Traditional Chinese Medicine, vol. 16, no. 8, pp. 81–84, 2009. View at Google Scholar
  28. F. Zong, “Clinical observation of Sanqi Panax Notoginseng Injection for angina pectoris,” Journal of Emergency in Traditional Chinese Medicine, vol. 18, no. 3, pp. 379–385, 2009. View at Google Scholar
  29. B. Li, “Clinical observation of Sanqi Panax Notoginseng Injection for stable angina,” China Journal of Traditional Chinese Medicine and Pharmacy, vol. 1, no. 7, pp. 98–113, 2011. View at Google Scholar
  30. F. M. Gao, J. X. Yang, F. X. Li et al., “Clinical observation of Sanqi Panax Notoginseng Injection for unstable angina and its effect on the level of CRP,” Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease, vol. 9, no. 9, pp. 1054–1058, 2011. View at Google Scholar
  31. “Meeting for treatment and prevention of angina of coronary heart disease and arrhythmia by integrated western and Chinese medicine efficacy criteria for angina of coronary heart disease,” Journal of Traditional Chinese Medicine, vol. 16, no. 10, p. 583, 1996.
  32. J. Wang and X. J. Xiong, “Current situation and perspectives of clinical study in integrative medicine in China,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 268542, 11 pages, 2012. View at Publisher · View at Google Scholar
  33. J. Wang, P. Q. Wang, and X. J. Xiong, “Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine,” Internal Medicine, vol. 2, no. 1000113, pp. 1–5, 2012. View at Google Scholar
  34. X. J. Xiong, X. C. Yang, Y. M. Liu, Y. Zhang, P. Q. Wang, and J. Wang, “Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science,” Hypertension Research, vol. 36, no. 7, pp. 570–579, 2013. View at Google Scholar